2007-2014
INSERM U850 PIST


Last Update: 29/08/2019

All publications are reported

  1. Influence of the ugt2b7 promoter region and exon 2 polymorphisms and comedications on acyl-mpag production in vitro and in adult renal transplant patients, Djebli, N.; Picard, N.; Rérolle, J.-P.; Le Meur, Y.; Marquet, P., Pharmacogenetics and Genomics 2007, 17, 321-330, http://doi.org/10.1097/FPC.0b013e32801430f8
  2. Non-invasive imaging correlates with histological and molecular characteristics of an osteosarcoma model: Application for early detection and follow-up of mdr phenotype, Dutour, A.; Leclers, D.; Monteil, J.; Paraf, F.; Charissoux, J. L.; Rousseau, R.; Rigaud, M., Anticancer Research 2007, 27, 4171-4178,
  3. Concomitant intensive chemoradiotherapy induction in non-metastatic inflammatory breast cancer: Long-term follow-up, Genet, D.; Lejeune, C.; Bonnier, P.; Aubard, Y.; Venat-Bouvet, L.; Adjadj, D. J.; Martin, J.; Labourey, J. L., et al., British Journal of Cancer 2007, 97, 883-887, http://doi.org/10.1038/sj.bjc.6603987
  4. Theoretical investigation of the formation of a new series of antioxidant depsides from the radiolysis of flavonoid compounds, Kozlowski, D.; Marsal, P.; Steel, M.; Mokrini, R.; Duroux, J.-L.; Lazzaroni, R.; Trouillas, P., Radiation Research 2007, 168, 243-252, http://doi.org/10.1667/RR0824.1
  5. Density functional theory study of the conformational, electronic, and antioxidant properties of natural chalcones, Kozlowski, D.; Trouillas, P.; Calliste, C.; Marsal, P.; Lazzaroni, R.; Duroux, J.-L., The Journal of Physical Chemistry. A 2007, 111, 1138-1145, http://doi.org/10.1021/jp066496+
  6. Potentially inappropriate medications in the elderly: A french consensus panel list, Laroche, M.-L.; Charmes, J.-P.; Merle, L., European Journal of Clinical Pharmacology 2007, 63, 725-731, http://doi.org/10.1007/s00228-007-0324-2
  7. Is inappropriate medication use a major cause of adverse drug reactions in the elderly?, Laroche, M.-L.; Charmes, J.-P.; Nouaille, Y.; Picard, N.; Merle, L., British Journal of Clinical Pharmacology 2007, 63, 177-186, http://doi.org/10.1111/j.1365-2125.2006.02831.x
  8. Cerebral ischemia probably related to isotretinoin, Laroche, M.-L.; Macian-Montoro, F.; Merle, L.; Vallat, J.-M., The Annals of Pharmacotherapy 2007, 41, 1073-1076, http://doi.org/10.1345/aph.1K028
  9. Individualized mycophenolate mofetil dosing based on drug exposure significantly improves patient outcomes after renal transplantation, Le Meur, Y.; Büchler, M.; Thierry, A.; Caillard, S.; Villemain, F.; Lavaud, S.; Etienne, I.; Westeel, P.-F., et al., American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2007, 7, 2496-2503, http://doi.org/10.1111/j.1600-6143.2007.01983.x
  10. [pharmacogenetics and immunosuppressor drugs: Impact and clinical interest in transplantation], Marquet, P.; Djebli, N.; Picard, N., Annales Pharmaceutiques Francaises 2007, 65, 382-389,
  11. Metabolism of sirolimus in the presence or absence of cyclosporine by genotyped human liver microsomes and recombinant cytochromes p450 3a4 and 3a5, Picard, N.; Djebli, N.; Sauvage, F.-L.; Marquet, P., Drug Metabolism and Disposition: The Biological Fate of Chemicals 2007, 35, 350-355, http://doi.org/10.1124/dmd.106.012161
  12. Q-switched yb-doped nonlinear microstructured fiber laser for the emission of broadband spectrum, Roy, A.; Laroche, M.; Roy, P.; Leproux, P.; Auguste, J.-L., Optics Letters 2007, 32, 3299-3301, http://doi.org/10.1364/ol.32.003299
  13. Current role of lc-ms in therapeutic drug monitoring, Saint-Marcoux, F.; Sauvage, F.-L.; Marquet, P., Analytical and Bioanalytical Chemistry 2007, 388, 1327-1349, http://doi.org/10.1007/s00216-007-1320-1
  14. Irinotecan-based chemotherapy in a metastatic colorectal cancer patient under haemodialysis for chronic renal dysfunction: Two cases considered, Vénat-Bouvet, L.; Saint-Marcoux, F.; Lagarde, C.; Peyronnet, P.; Lebrun-Ly, V.; Tubiana-Mathieu, N., Anti-Cancer Drugs 2007, 18, 977-980, http://doi.org/10.1097/CAD.0b013e32811d69cb
  15. Microcalorimetric study of the inhibition of butyrylcholinesterase by carbamates, Debord, J.; Laubarie, C.; Dantoine, T., Analytical Biochemistry 2008, 373, 247-252, http://doi.org/10.1016/j.ab.2007.09.023
  16. Protective effect of candesartan in experimental ischemic stroke in the rat mediated by at2 and at4 receptors, Faure, S.; Bureau, A.; Oudart, N.; Javellaud, J.; Fournier, A.; Achard, J.-M., Journal of Hypertension 2008, 26, 2008-2015, http://doi.org/10.1097/HJH.0b013e32830dd5ee
  17. Identification of acepromazine in hair: An illustration of the difficulties encountered in investigating drug-facilitated crimes, Gaulier, J.-M.; Sauvage, F.-L.; Pauthier, H.; Saint-Marcoux, F.; Marquet, P.; Lachâtre, G., Journal of Forensic Sciences 2008, 53, 755-759, http://doi.org/10.1111/j.1556-4029.2008.00706.x
  18. [uterine transplantation: Animal and human studies], Gauthier, T.; Hardeman, S.; Piver, P.; Aubard, Y., Gynecologie, Obstetrique & Fertilite 2008, 36, 1218-1223, http://doi.org/10.1016/j.gyobfe.2008.09.011
  19. [evaluation of accuracy of three assays for human papillomavirus detection and typing: Hybrid capture 2, hpv consensus kit and amplicor hpv], Hantz, S.; Caly, H.; Decroisette, E.; Dutrop, A.; Bakeland, D.; Pascal, B.; Darreye, G.; Dussartre, C., et al., Pathologie-Biologie 2008, 56, 29-35, http://doi.org/10.1016/j.patbio.2007.09.006
  20. An unusual pulmonary complication of cytomegalovirus infection in a renal transplant recipient, Jacques, J.; Dallocchio, A.; Dickson, Z.; Bocquentin, F.; Jebali, H.; Aldigier, J.-C.; Essig, M.; Rerolle, J.-P., NDT plus 2008, 1, 236-238, http://doi.org/10.1093/ndtplus/sfn055
  21. [adrenal metastasis: Survival following surgical resection], Kapella, M.; Genet, D.; Pech De Laclause, B.; Durand-Fontanier, S.; Lachachi, M.; Fabre, A.; Valleix, D.; Descottes, B., Journal De Chirurgie 2008, 145, 346-349,
  22. Ribavirin exposure after the first dose is predictive of sustained virological response in chronic hepatitis c, Loustaud-Ratti, V.; Alain, S.; Rousseau, A.; Hubert, I. F.; Sauvage, F. L.; Marquet, P.; Denis, F.; Lunel, F., et al., Hepatology (Baltimore, Md.) 2008, 47, 1453-1461, http://doi.org/10.1002/hep.22217
  23. [pharmacokinetics and therapeutic drug monitoring of anticancer agents], Marquet, P.; Rousseau, A., Bulletin Du Cancer 2008, 95, 903-909, http://doi.org/10.1684/bdc.2008.0725
  24. [imaging of female infertility], Maubon, A.; Pouquet, M.; Piver, P.; Mazet, N.; Viala-Trentini, M.; Rouanet, J. P., Journal De Radiologie 2008, 89, 172-183,
  25. [splenic trauma: An unusual complication of colonoscopy with polypectomy], Pichon, N.; Mathonnet, M.; Verdière, F.; Carrier, P., Gastroenterologie Clinique Et Biologique 2008, 32, 123-127, http://doi.org/10.1016/j.gcb.2007.10.005
  26. [post therapeutic female pelvis mr imaging], Pouquet, M.; Mathonnet, M.; Aubard, Y.; Rouanet, J.; Maubon, A., Journal De Radiologie 2008, 89, 142-161,
  27. Pitfalls and prevention strategies for liquid chromatography-tandem mass spectrometry in the selected reaction-monitoring mode for drug analysis, Sauvage, F.-L.; Gaulier, J.-M.; Lachâtre, G.; Marquet, P., Clinical Chemistry 2008, 54, 1519-1527, http://doi.org/10.1373/clinchem.2008.105478
  28. Mechanism of the antioxidant action of silybin and 2,3-dehydrosilybin flavonolignans: A joint experimental and theoretical study, Trouillas, P.; Marsal, P.; Svobodová, A.; Vostálová, J.; Gazák, R.; Hrbác, J.; Sedmera, P.; Kren, V., et al., The Journal of Physical Chemistry. A 2008, 112, 1054-1063, http://doi.org/10.1021/jp075814h
  29. Free radical scavenging properties of guaiacol oligomers: A combined experimental and quantum study of the guaiacyl-moiety role, Anouar, E.; Calliste, C. A.; Kosinová, P.; Di Meo, F.; Duroux, J. L.; Champavier, Y.; Marakchi, K.; Trouillas, P., The Journal of Physical Chemistry. A 2009, 113, 13881-13891, http://doi.org/10.1021/jp906285b
  30. New aspects of the antioxidant properties of phenolic acids: A combined theoretical and experimental approach, Anouar, E.; Kosinová, P.; Kozlowski, D.; Mokrini, R.; Duroux, J. L.; Trouillas, P., Physical chemistry chemical physics: PCCP 2009, 11, 7659-7668,
  31. [ovarian tumors], Aubard, Y.; Gauthier, T., La Revue Du Praticien 2009, 59, 1127-1132; quiz 1133,
  32. [should we change our indications for ovarian tissue cryopreservation?], Aubard, Y.; Piver, P.; Gauthier, T., Gynecologie, Obstetrique & Fertilite 2009, 37, 773-774, http://doi.org/10.1016/j.gyobfe.2009.08.002
  33. Tacrolimus population pharmacokinetic-pharmacogenetic analysis and bayesian estimation in renal transplant recipients, Benkali, K.; Prémaud, A.; Picard, N.; Rérolle, J.-P.; Toupance, O.; Hoizey, G.; Turcant, A.; Villemain, F., et al., Clinical Pharmacokinetics 2009, 48, 805-816, http://doi.org/10.2165/11318080-000000000-00000
  34. Microcalorimetric study of the inhibition of butyrylcholinesterase by paraoxon, Debord, J.; Harel, M.; Verneuil, B.; Bollinger, J.-C.; Dantoine, T., Analytical Biochemistry 2009, 389, 97-101, http://doi.org/10.1016/j.ab.2009.03.041
  35. A renal transplant recipient with intraglomerular candida albicans, Dickson, Z.; Bocquentin, F.; Essig, M.; Paraf, F.; Aldigier, J.-C.; Rérolle, J.-P., NDT plus 2009, 2, 329-330, http://doi.org/10.1093/ndtplus/sfp051
  36. [low invasion in sentinel lymph node according to the european working group in breast screening pathology (ewgbsp) recommendations and non sentinel invasion risk in breast cancer], Gauthier, T.; Fermeaux, V.; Mollard, J.; Aubard, Y., Gynecologie, Obstetrique & Fertilite 2009, 37, 481-487, http://doi.org/10.1016/j.gyobfe.2009.04.012
  37. Axillary recurrence after negative sentinel lymph node biopsy under local anesthesia in breast cancer, Gauthier, T.; Mollard, J.; Fermeaux, V.; Kapella, M.; Aubard, Y., European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2009, 35, 464-468, http://doi.org/10.1016/j.ejso.2008.09.008
  38. Effect of mycophenolate acyl-glucuronide on human recombinant type 2 inosine monophosphate dehydrogenase, Gensburger, O.; Picard, N.; Marquet, P., Clinical Chemistry 2009, 55, 986-993, http://doi.org/10.1373/clinchem.2008.113936
  39. [potentially inappropriate medications in the elderly: A list adapted to french medical practice], Laroche, M.-L.; Bouthier, F.; Merle, L.; Charmes, J.-P., La Revue De Medecine Interne 2009, 30, 592-601, http://doi.org/10.1016/j.revmed.2008.08.010
  40. Inappropriate medications in the elderly, Laroche, M. L.; Charmes, J. P.; Bouthier, F.; Merle, L., Clinical Pharmacology and Therapeutics 2009, 85, 94-97, http://doi.org/10.1038/clpt.2008.214
  41. Optimizing ribavirin dosage: A new challenge to improve treatment efficacy in genotype 1 hepatitis c patients, Loustaud-Ratti, V.; Stanke-Labesque, F.; Marquet, P.; Gagnieu, M.-C.; Maynard, M.; Babany, G.; Trépo, C.; OPTIRIB, F. R. G., Gastroenterologie Clinique Et Biologique 2009, 33, 580-583, http://doi.org/10.1016/j.gcb.2009.04.009
  42. Performance of the new mycophenolate assay based on impdh enzymatic activity for pharmacokinetic investigations and setup of bayesian estimators in different populations of allograft recipients, Marquet, P.; Saint-Marcoux, F.; Prémaud, A.; Sauvage, F.-L.; Jaqz-Aigrain, E.; Knoop, C.; Lebranchu, Y.; Tiberi, M., et al., Therapeutic Drug Monitoring 2009, 31, 443-450, http://doi.org/10.1097/FTD.0b013e3181a8f0ae
  43. Pharmacokinetic optimization of immunosuppressive therapy in thoracic transplantation: Part ii, Monchaud, C.; Marquet, P., Clinical Pharmacokinetics 2009, 48, 489-516, http://doi.org/10.2165/11317240-000000000-00000
  44. Pharmacokinetic optimization of immunosuppressive therapy in thoracic transplantation: Part i, Monchaud, C.; Marquet, P., Clinical Pharmacokinetics 2009, 48, 419-462, http://doi.org/10.2165/11317230-000000000-00000
  45. General unknown screening procedure for the characterization of human drug metabolites: Application to loratadine phase i metabolism, Picard, N.; Dridi, D.; Sauvage, F.-L.; Boughattas, N. A.; Marquet, P., Journal of Separation Science 2009, 32, 2209-2217, http://doi.org/10.1002/jssc.200900099
  46. Pharmacokinetic modelling and development of bayesian estimators for therapeutic drug monitoring of mycophenolate mofetil in reduced-intensity haematopoietic stem cell transplantation, Saint-Marcoux, F.; Royer, B.; Debord, J.; Larosa, F.; Legrand, F.; Deconinck, E.; Kantelip, J.-P.; Marquet, P., Clinical Pharmacokinetics 2009, 48, 667-675, http://doi.org/10.2165/11317140-000000000-00000
  47. General unknown screening procedure for the characterization of human drug metabolites in forensic toxicology: Applications and constraints, Sauvage, F.-L.; Picard, N.; Saint-Marcoux, F.; Gaulier, J.-M.; Lachâtre, G.; Marquet, P., Journal of Separation Science 2009, 32, 3074-3083, http://doi.org/10.1002/jssc.200900092
  48. Feasibility of ribavirin therapeutic drug monitoring in hepatitis c, Sauvage, F.-L.; Stanke-Labesque, F.; Gagnieu, M.-C.; Jourdil, J.-F.; Babany, G.; Marquet, P., Therapeutic Drug Monitoring 2009, 31, 374-381, http://doi.org/10.1097/FTD.0b013e3181a665e3
  49. Population pharmacokinetics and bayesian estimation of tacrolimus exposure in renal transplant recipients on a new once-daily formulation, Benkali, K.; Rostaing, L.; Premaud, A.; Woillard, J.-B.; Saint-Marcoux, F.; Urien, S.; Kamar, N.; Marquet, P., et al., Clinical Pharmacokinetics 2010, 49, 683-692, http://doi.org/10.2165/11535950-000000000-00000
  50. [sternal cleft: Repair during the neonatal period], Beurdeley, M.; Gauthier, T.; Bedu, A.; Fourcade, L., Archives De Pediatrie: Organe Officiel De La Societe Francaise De Pediatrie 2010, 17, 1477-1479, http://doi.org/10.1016/j.arcped.2010.07.012
  51. Conservative treatment of big yolk sac tumour of the ovary in young girl, Beurdeley, M.; Gauthier, T.; Piguet, C.; Fourcade, L., Journal of Visceral Surgery 2010, 147, e265-267, http://doi.org/10.1016/j.jviscsurg.2010.08.007
  52. Familial 18 centromere variant resulting in difficulties in interpreting prenatal interphase fish, Bourthoumieu, S.; Esclaire, F.; Terro, F.; Brosset, P.; Fiorenza, M.; Aubard, V.; Beguet, M.; Yardin, C., Morphologie: Bulletin De l’Association Des Anatomistes 2010, 94, 68-72, http://doi.org/10.1016/j.morpho.2010.02.016
  53. Osteonecrosis of the jaw induced by clodronate, an alkylbiphosphonate: Case report and literature review, Crépin, S.; Laroche, M.-L.; Sarry, B.; Merle, L., European Journal of Clinical Pharmacology 2010, 66, 547-554, http://doi.org/10.1007/s00228-010-0822-5
  54. [a child behind an epilepsy: Clinic and therapeutic wavering], Dantoine, F.; Castaing, M. A.; Dumont, C.; Laroche, C.; Thuillier, C., Archives De Pediatrie: Organe Officiel De La Societe Francaise De Pediatrie 2010, 17, 654-655, http://doi.org/10.1016/S0929-693X(10)70045-2
  55. Screening of pesticides in blood with liquid chromatography-linear ion trap mass spectrometry, Dulaurent, S.; Moesch, C.; Marquet, P.; Gaulier, J.-M.; Lachâtre, G., Analytical and Bioanalytical Chemistry 2010, 396, 2235-2249, http://doi.org/10.1007/s00216-009-3443-z
  56. Crystal-storing histiocytosis with renal fanconi syndrome: Pathological and molecular characteristics compared with classical myeloma-associated fanconi syndrome, El Hamel, C.; Thierry, A.; Trouillas, P.; Bridoux, F.; Carrion, C.; Quellard, N.; Goujon, J.-M.; Aldigier, J.-C., et al., Nephrology, Dialysis, Transplantation: Official Publication of the European Dialysis and Transplant Association – European Renal Association 2010, 25, 2982-2990, http://doi.org/10.1093/ndt/gfq129
  57. [why not creating a n4 stage in breast cancer?], Gauthier, T.; Bourneton, N.; Mollard, J.; Aubard, Y., Gynecologie, Obstetrique & Fertilite 2010, 38, 439-441, http://doi.org/10.1016/j.gyobfe.2010.02.002
  58. [how i… Remove axillary sentinel lymph node under local anesthesia], Gauthier, T.; Garuchet-Bigot, A.; Mollard, J.; Aubard, Y., Gynecologie, Obstetrique & Fertilite 2010, 38, 418-419, http://doi.org/10.1016/j.gyobfe.2010.04.004
  59. Contralateral axillary involvement in breast cancer recurrence: Locoregional disease or metastasis?, Gauthier, T.; Monteil, J.; Bourneton, N.; Jammet, I.; Tubiana, N.; Aubard, Y., European Journal of Gynaecological Oncology 2010, 31, 694-696,
  60. [chemotherapy and women fertility preservation], Gauthier, T.; Piver, P.; Durand, L.-M.; Donadel, L.; Pech, J.-C.; Roux, C.; Aubard, Y., Presse Medicale (Paris, France: 1983) 2010, 39, 786-793, http://doi.org/10.1016/j.lpm.2010.01.011
  61. Polymorphisms in type i and ii inosine monophosphate dehydrogenase genes and association with clinical outcome in patients on mycophenolate mofetil, Gensburger, O.; Van Schaik, R. H. N.; Picard, N.; Le Meur, Y.; Rousseau, A.; Woillard, J.-B.; Van Gelder, T.; Marquet, P., Pharmacogenetics and Genomics 2010, 20, 537-543, http://doi.org/10.1097/FPC.0b013e32833d8cf5
  62. Drug-resistant cytomegalovirus in transplant recipients: A french cohort study, Hantz, S.; Garnier-Geoffroy, F.; Mazeron, M.-C.; Garrigue, I.; Merville, P.; Mengelle, C.; Rostaing, L.; Saint Marcoux, F., et al., The Journal of Antimicrobial Chemotherapy 2010, 65, 2628-2640, http://doi.org/10.1093/jac/dkq368
  63. Fertility after embolization of the uterine arteries to treat obstetrical hemorrhage: A review of 53 cases, Hardeman, S.; Decroisette, E.; Marin, B.; Vincelot, A.; Aubard, Y.; Pouquet, M.; Maubon, A., Fertility and Sterility 2010, 94, 2574-2579, http://doi.org/10.1016/j.fertnstert.2010.02.052
  64. Severe sirolimus-induced acute hepatitis in a renal transplant recipient, Jacques, J.; Dickson, Z.; Carrier, P.; Essig, M.; Guillaudeau, A.; Lacour, C.; Bocquentin, F.; Aldigier, J.-C., et al., Transplant International: Official Journal of the European Society for Organ Transplantation 2010, 23, 967-970, http://doi.org/10.1111/j.1432-2277.2010.01100.x
  65. Counterpoint: Is pharmacokinetic or pharmacodynamic monitoring of calcineurin inhibition therapy necessary?, Marquet, P., Clinical Chemistry 2010, 56, 736-739, http://doi.org/10.1373/clinchem.2009.138693
  66. Stability of ribavirin concentrations depending on the type of blood collection tube and preanalytical conditions, Marquet, P.; Sauvage, F.-L.; Loustaud-Ratti, V.; Babany, G.; Rousseau, A.; Lachâtre, G., Therapeutic Drug Monitoring 2010, 32, 237-241, http://doi.org/10.1097/FTD.0b013e3181d3f686
  67. Uterine junctional zone at magnetic resonance imaging: A predictor of in vitro fertilization implantation failure, Maubon, A.; Faury, A.; Kapella, M.; Pouquet, M.; Piver, P., The Journal of Obstetrics and Gynaecology Research 2010, 36, 611-618, http://doi.org/10.1111/j.1447-0756.2010.01189.x
  68. The role of organic anion-transporting polypeptides and their common genetic variants in mycophenolic acid pharmacokinetics, Picard, N.; Yee, S. W.; Woillard, J.-B.; Lebranchu, Y.; Le Meur, Y.; Giacomini, K. M.; Marquet, P., Clinical Pharmacology and Therapeutics 2010, 87, 100-108, http://doi.org/10.1038/clpt.2009.205
  69. Contribution of the different udp-glucuronosyltransferase (ugt) isoforms to buprenorphine and norbuprenorphine metabolism and relationship with the main ugt polymorphisms in a bank of human liver microsomes, Rouguieg, K.; Picard, N.; Sauvage, F.-L.; Gaulier, J.-M.; Marquet, P., Drug Metabolism and Disposition: The Biological Fate of Chemicals 2010, 38, 40-45, http://doi.org/10.1124/dmd.109.029546
  70. Cost-effectiveness analysis of individualized mycophenolate mofetil dosing in kidney transplant patients in the apomygre trial, Rousseau, A.; Laroche, M.-L.; Venisse, N.; Loichot-Roselmac, C.; Turcant, A.; Hoizey, G.; Compagnon, P.; Hary, L., et al., Transplantation 2010, 89, 1255-1262, http://doi.org/10.1097/TP.0b013e3181d75952
  71. Pharmacokinetic modeling and development of bayesian estimators in kidney transplant patients receiving the tacrolimus once-daily formulation, Saint-Marcoux, F.; Debord, J.; Undre, N.; Rousseau, A.; Marquet, P., Therapeutic Drug Monitoring 2010, 32, 129-135, http://doi.org/10.1097/FTD.0b013e3181cc70db
  72. Risk of diarrhoea in a long-term cohort of renal transplant patients given mycophenolate mofetil: The significant role of the ugt1a8 2 variant allele, Woillard, J.-B.; Rerolle, J.-P.; Picard, N.; Rousseau, A.; Drouet, M.; Munteanu, E.; Essig, M.; Marquet, P., et al., British Journal of Clinical Pharmacology 2010, 69, 675-683, http://doi.org/10.1111/j.1365-2125.2010.03625.x
  73. Donor p-gp polymorphisms strongly influence renal function and graft loss in a cohort of renal transplant recipients on cyclosporine therapy in a long-term follow-up, Woillard, J.-B.; Rerolle, J.-P.; Picard, N.; Rousseau, A.; Guillaudeau, A.; Munteanu, E.; Essig, M.; Drouet, M., et al., Clinical Pharmacology and Therapeutics 2010, 88, 95-100, http://doi.org/10.1038/clpt.2010.62
  74. [sentinel node biopsy under local anesthesia in breast cancer: The pros], Aubard, Y.; Gauthier, T.; Mollard, J., Gynecologie, Obstetrique & Fertilite 2011, 39, 259-261, http://doi.org/10.1016/j.gyobfe.2011.02.004
  75. Erythropoietin restores c-fiber function and prevents pressure ulcer formation in diabetic mice, Demiot, C.; Sarrazy, V.; Javellaud, J.; Gourloi, L.; Botelle, L.; Oudart, N.; Achard, J.-M., The Journal of Investigative Dermatology 2011, 131, 2316-2322, http://doi.org/10.1038/jid.2011.211
  76. Are all cases of low-grade mosaic trisomy 13 in amniotic fluid with no fetal malformation in fact confined placental mosaicism? A case report, Etoubleau, C.; Bourthoumieu, S.; Fiorenza, M.; Aubard, V.; Yardin, C., Morphologie: Bulletin De l’Association Des Anatomistes 2011, 95, 142-145, http://doi.org/10.1016/j.morpho.2011.07.117
  77. Radiodermatitis prevention with sucralfate in breast cancer: Fundamental and clinical studies, Falkowski, S.; Trouillas, P.; Duroux, J.-L.; Bonnetblanc, J.-M.; Clavère, P., Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer 2011, 19, 57-65, http://doi.org/10.1007/s00520-009-0788-y
  78. Uterine allotransplantation in ewes using an aortocava patch, Gauthier, T.; Bertin, F.; Fourcade, L.; Maubon, A.; Saint Marcoux, F.; Piver, P.; Marquet, P.; Pommepuy, I., et al., Human Reproduction (Oxford, England) 2011, 26, 3028-3036, http://doi.org/10.1093/humrep/der288
  79. [conservative management of placenta percreta invading the bladder: Be patient], Gauthier, T.; Garuchet-Bigot, A.; Benacquista, M.; Odin, I.; Decroisette, E.; Vincelot, A.; Nathan-Denizot, N.; Maubon, A., et al., Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction 2011, 40, 169-173, http://doi.org/10.1016/j.jgyn.2010.09.010
  80. [not available], Goirand, F.; Royer, B.; Hulin, A.; Saint-Marcoux, F.; Thérapeutique, p. l. g. S. T. P. d. l. S. F. d. P. e. d., Therapie 2011, 66, 57-61, http://doi.org/10.2515/therapie/2010025
  81. Dimerisation process of silybin-type flavonolignans: Insights from theory, Košinová, P.; Gažák, R.; Duroux, J.-L.; Lazzaroni, R.; Křen, V.; Assfeld, X.; Trouillas, P., Chemphyschem: A European Journal of Chemical Physics and Physical Chemistry 2011, 12, 1135-1142, http://doi.org/10.1002/cphc.201100066
  82. Quantitative proteomic analysis of cyclosporine-induced toxicity in a human kidney cell line and comparison with tacrolimus, Lamoureux, F.; Mestre, E.; Essig, M.; Sauvage, F. L.; Marquet, P.; Gastinel, L. N., Journal of Proteomics 2011, 75, 677-694, http://doi.org/10.1016/j.jprot.2011.09.005
  83. Determination of dodine in fruit samples by liquid chromatography electrospray ionization-tandem mass spectrometry, Le Grand, R.; Saint-Marcoux, F.; Dulaurent, S.; Sauvage, F.-L.; Moesch, C.; Lachâtre, G., Journal of AOAC International 2011, 94, 300-306,
  84. Pharmacological exposure to ribavirin: A key player in the complex network of factors implicated in virological response and anaemia in hepatitis c treatment, Loustaud-Ratti, V.; Carrier, P.; Rousseau, A.; Maynard, M.; Babany, G.; Alain, S.; Trépo, C.; De Ledinghen, V., et al., Digestive and Liver Disease: Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2011, 43, 850-855, http://doi.org/10.1016/j.dld.2011.04.002
  85. Non-invasive detection of hepatic amyloidosis: Fibroscan, a new tool, Loustaud-Ratti, V. R.; Cypierre, A.; Rousseau, A.; Yagoubi, F.; Abraham, J.; Fauchais, A.-L.; Carrier, P.; Lefebvre, A., et al., Amyloid: The International Journal of Experimental and Clinical Investigation: The Official Journal of the International Society of Amyloidosis 2011, 18, 19-24, http://doi.org/10.3109/13506129.2010.543443
  86. Lymph node assessment with (18)f-fdg-pet and mri in uterine cervical cancer, Monteil, J.; Maubon, A.; Leobon, S.; Roux, S.; Marin, B.; Renaudie, J.; Genet, D.; Fermeaux, V., et al., Anticancer Research 2011, 31, 3865-3871,
  87. Interaction of sirolimus and everolimus with hepatic and intestinal organic anion-transporting polypeptide transporters, Picard, N.; Levoir, L.; Lamoureux, F.; Yee, S. W.; Giacomini, K. M.; Marquet, P., Xenobiotica; the Fate of Foreign Compounds in Biological Systems 2011, 41, 752-757, http://doi.org/10.3109/00498254.2011.573882
  88. The influence of pharmacogenetics and cofactors on clinical outcomes in kidney transplantation, Picard, N.; Marquet, P., Expert Opinion on Drug Metabolism & Toxicology 2011, 7, 731-743, http://doi.org/10.1517/17425255.2011.570260
  89. Cyp3a5 genotype does not influence everolimus in vitro metabolism and clinical pharmacokinetics in renal transplant recipients, Picard, N.; Rouguieg-Malki, K.; Kamar, N.; Rostaing, L.; Marquet, P., Transplantation 2011, 91, 652-656, http://doi.org/10.1097/TP.0b013e31820ae4ac
  90. Value of liver stiffness measured by transient elastography in the liver transplant pre-operative evaluation of the potential deceased liver donors: Preliminary study, Pichon, N.; Loustaud-Ratti, V.; Clavel, M.; Carrier, P.; Amiel, J. B.; Labrousse, F., Clinical Transplantation 2011, 25, E205-210, http://doi.org/10.1111/j.1399-0012.2010.01386.x
  91. Inhibition of t-cell activation and proliferation by mycophenolic acid in patients awaiting liver transplantation: Pk/pd relationships, Prémaud, A.; Rousseau, A.; Johnson, G.; Canivet, C.; Gandia, P.; Muscari, F.; Peron, J. M.; Rostaing, L., et al., Pharmacological Research 2011, 63, 432-438, http://doi.org/10.1016/j.phrs.2011.01.005
  92. Population pharmacokinetics of mycophenolic acid in pediatric renal transplant patients using parametric and nonparametric approaches, Prémaud, A.; Weber, L. T.; Tönshoff, B.; Armstrong, V. W.; Oellerich, M.; Urien, S.; Marquet, P.; Rousseau, A., Pharmacological Research 2011, 63, 216-224, http://doi.org/10.1016/j.phrs.2010.10.017
  93. Development and evaluation of a simulation procedure to take into account various assays for the bayesian dose adjustment of tacrolimus, Saint-Marcoux, F.; Debord, J.; Parant, F.; Labalette, M.; Kamar, N.; Rostaing, L.; Rousseau, A.; Marquet, P., Therapeutic Drug Monitoring 2011, 33, 171-177, http://doi.org/10.1097/FTD.0b013e31820d6ef7
  94. Development of a bayesian estimator for the therapeutic drug monitoring of mycophenolate mofetil in children with idiopathic nephrotic syndrome, Saint-Marcoux, F.; Guigonis, V.; Decramer, S.; Gandia, P.; Ranchin, B.; Parant, F.; Bessenay, L.; Libert, F., et al., Pharmacological Research 2011, 63, 423-431, http://doi.org/10.1016/j.phrs.2011.01.009
  95. Large scale analysis of routine dose adjustments of mycophenolate mofetil based on global exposure in renal transplant patients, Saint-Marcoux, F.; Vandierdonck, S.; Prémaud, A.; Debord, J.; Rousseau, A.; Marquet, P., Therapeutic Drug Monitoring 2011, 33, 285-294, http://doi.org/10.1097/FTD.0b013e31821633a6
  96. Post-transplant lymphoproliferative disease (ptld): Pharmacological, virological and other determinants, Stojanova, J.; Caillard, S.; Rousseau, A.; Marquet, P., Pharmacological Research 2011, 63, 1-7, http://doi.org/10.1016/j.phrs.2010.10.016
  97. Population pharmacokinetic model and bayesian estimator for two tacrolimus formulations–twice daily prograf and once daily advagraf, Woillard, J.-B.; de Winter, B. C. M.; Kamar, N.; Marquet, P.; Rostaing, L.; Rousseau, A., British Journal of Clinical Pharmacology 2011, 71, 391-402, http://doi.org/10.1111/j.1365-2125.2010.03837.x
  98. [lead poisoning by fishing sinker ingestion], Carrier, P.; Legros, R.; Le Sidaner, A.; Morel, A.; Harry, P.; Moesch, C.; Sautereau, D.; Ly, K.-H., et al., La Revue De Medecine Interne 2012, 33, 697-699, http://doi.org/10.1016/j.revmed.2012.09.004
  99. Bordetella holmesii bacteremia in a renal transplant recipient: Emergence of a new pathogen, Chambaraud, T.; Dickson, Z.; Ensergueix, G.; Barraud, O.; Essig, M.; Lacour, C.; Allard, J.; Bocquentin, F., et al., Transplant Infectious Disease: An Official Journal of the Transplantation Society 2012, 14, E134-136, http://doi.org/10.1111/tid.12009
  100. [photodynamic therapy for the treatment of extramammary paget’s disease], Clément, E.; Sparsa, A.; Doffoel-Hantz, V.; Durox, H.; Prey, S.; Bonnetblanc, J.-M.; Caly, H.; Aubard, Y., et al., Annales De Dermatologie Et De Venereologie 2012, 139, 103-108, http://doi.org/10.1016/j.annder.2011.10.414
  101. Bayesian estimation of mycophenolate mofetil in lung transplantation, using a population pharmacokinetic model developed in kidney and lung transplant recipients, de Winter, B. C. M.; Monchaud, C.; Prémaud, A.; Pison, C.; Kessler, R.; Reynaud-Gaubert, M.; Dromer, C.; Stern, M., et al., Clinical Pharmacokinetics 2012, 51, 29-39, http://doi.org/10.2165/11594050-000000000-00000
  102. Voriconazole stability in cement spacers, Denes, E.; Fiorenza, F.; Saint-Marcoux, F.; Megherbi, M.; Dupon, M.; Weinbreck, P., Medecine Et Maladies Infectieuses 2012, 42, 567-568, http://doi.org/10.1016/j.medmal.2012.07.007
  103. Calcineurin regulation of cytoskeleton organization: A new paradigm to analyse the effects of calcineurin inhibitors on the kidney, Descazeaud, V.; Mestre, E.; Marquet, P.; Essig, M., Journal of Cellular and Molecular Medicine 2012, 16, 218-227, http://doi.org/10.1111/j.1582-4934.2011.01398.x
  104. Highlights on anthocyanin pigmentation and copigmentation: A matter of flavonoid π-stacking complexation to be described by dft-d, Di Meo, F.; Sancho Garcia, J. C.; Dangles, O.; Trouillas, P., Journal of Chemical Theory and Computation 2012, 8, 2034-2043, http://doi.org/10.1021/ct300276p
  105. Simultaneous evaluation of six human glucuronidation activities in liver microsomes using liquid chromatography-tandem mass spectrometry, Gagez, A.-L.; Rouguieg-Malki, K.; Sauvage, F.-L.; Marquet, P.; Picard, N., Analytical Biochemistry 2012, 427, 52-59, http://doi.org/10.1016/j.ab.2012.04.031
  106. Lanreotide autogel 90 mg and lymphorrhea prevention after axillary node dissection in breast cancer: A phase iii double blind, randomized, placebo-controlled trial, Gauthier, T.; Garuchet-Bigot, A.; Marin, B.; Mollard, J.; Loum, O.; Fermeaux, V.; Jammet, I.; Kanoun, D., et al., European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2012, 38, 902-909, http://doi.org/10.1016/j.ejso.2012.05.009
  107. [the age of the patient over 70 is a contraindication to perform para-aortic lymphadenectomy for ovarian cancer], Gauthier, T.; Gouy, S.; Uzan, C.; Kane, A.; Morice, P., Gynecologie, Obstetrique & Fertilite 2012, 40, 330-332, http://doi.org/10.1016/j.gyobfe.2012.02.017
  108. Obesity and cervical ripening failure risk, Gauthier, T.; Mazeau, S.; Dalmay, F.; Eyraud, J.-L.; Catalan, C.; Marin, B.; Aubard, Y., The Journal of Maternal-Fetal & Neonatal Medicine: The Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 2012, 25, 304-307, http://doi.org/10.3109/14767058.2011.575485
  109. [uterus transplantation. Current situation], Gauthier, T.; Piver, P.; Mesnard, C.; Marquet, P.; Pichon, N.; Guillaudeau, A.; Drouet, M.; Gardet, E., et al., Gynecologie, Obstetrique & Fertilite 2012, 40, 691-694, http://doi.org/10.1016/j.gyobfe.2012.09.011
  110. Positioning of antioxidant quercetin and its metabolites in lipid bilayer membranes: Implication for their lipid-peroxidation inhibition, Košinová, P.; Berka, K.; Wykes, M.; Otyepka, M.; Trouillas, P., The Journal of Physical Chemistry. B 2012, 116, 1309-1318, http://doi.org/10.1021/jp208731g
  111. Mapping cyclosporine-induced changes in protein secretion by renal cells using stable isotope labeling with amino acids in cell culture (silac), Lamoureux, F.; Gastinel, L. N.; Mestre, E.; Marquet, P.; Essig, M., Journal of Proteomics 2012, 75, 3674-3687, http://doi.org/10.1016/j.jprot.2012.04.024
  112. Sirolimus and everolimus intestinal absorption and interaction with calcineurin inhibitors: A differential effect between cyclosporine and tacrolimus, Lamoureux, F.; Picard, N.; Boussera, B.; Sauvage, F.-L.; Marquet, P., Fundamental & Clinical Pharmacology 2012, 26, 463-472, http://doi.org/10.1111/j.1472-8206.2011.00957.x
  113. Simultaneous determination of five synthetic pyrethroid metabolites in urine by liquid chromatography-tandem mass spectrometry: Application to 39 persons without known exposure to pyrethroids, Le Grand, R.; Dulaurent, S.; Gaulier, J. M.; Saint-Marcoux, F.; Moesch, C.; Lachâtre, G., Toxicology Letters 2012, 210, 248-253, http://doi.org/10.1016/j.toxlet.2011.08.016
  114. Lc-ms vs. Gc-ms, online extraction systems, advantages of technology for drug screening assays, Marquet, P., Methods in Molecular Biology (Clifton, N.J.) 2012, 902, 15-27, http://doi.org/10.1007/978-1-61779-934-1_2
  115. Population pharmacokinetic modelling and design of a bayesian estimator for therapeutic drug monitoring of tacrolimus in lung transplantation, Monchaud, C.; de Winter, B. C.; Knoop, C.; Estenne, M.; Reynaud-Gaubert, M.; Pison, C.; Stern, M.; Kessler, R., et al., Clinical Pharmacokinetics 2012, 51, 175-186, http://doi.org/10.2165/11594760-000000000-00000
  116. Untargeted screening of urinary peptides with liquid chromatography coupled to hybrid linear-ion trap tandem mass spectrometry, Sauvage, F.-L.; Gastinel, L. N.; Marquet, P., Journal of Chromatography. A 2012, 1259, 138-147, http://doi.org/10.1016/j.chroma.2012.04.006
  117. Lc-ms/ms screen for xenobiotics and metabolites, Sauvage, F.-L.; Marquet, P., Methods in Molecular Biology (Clifton, N.J.) 2012, 902, 129-138, http://doi.org/10.1007/978-1-61779-934-1_11
  119. Maribavir use in practice for cytomegalovirus infection in french transplantation centers, Alain, S.; Revest, M.; Veyer, D.; Essig, M.; Rerolles, J. P.; Rawlinson, W.; Mengelle, C.; Huynh, A., et al., Transplantation Proceedings 2013, 45, 1603-1607, http://doi.org/10.1016/j.transproceed.2013.01.082
  120. [presumed ovarian benign tumors and fertility], Aubard, Y.; Poirot, C., Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction 2013, 42, 794-801, http://doi.org/10.1016/j.jgyn.2013.09.034
  121. Electrical impedance to detect accidental nerve puncture during ultrasound-guided peripheral nerve blocks, Bardou, P.; Merle, J.-C.; Woillard, J.-B.; Nathan-Denizot, N.; Beaulieu, P., Canadian Journal of Anaesthesia = Journal Canadien D’anesthesie 2013, 60, 253-258, http://doi.org/10.1007/s12630-012-9845-y
  122. Acute liver toxicity due to methylprednisolone: Consider this diagnosis in the context of autoimmunity, Carrier, P.; Godet, B.; Crepin, S.; Magy, L.; Debette-Gratien, M.; Pillegand, B.; Jacques, J.; Sautereau, D., et al., Clinics and Research in Hepatology and Gastroenterology 2013, 37, 100-104, http://doi.org/10.1016/j.clinre.2012.10.015
  123. Epidemiology of distal humerus fractures in the elderly, Charissoux, J.-L.; Vergnenegre, G.; Pelissier, M.; Fabre, T.; Mansat, P.; SOFCOT, Orthopaedics & traumatology, surgery & research: OTSR 2013, 99, 765-769, http://doi.org/10.1016/j.otsr.2013.08.002
  124. Impact of longitudinal exposure to mycophenolic acid on acute rejection in renal-transplant recipients using a joint modeling approach, Daher Abdi, Z.; Essig, M.; Rizopoulos, D.; Le Meur, Y.; Prémaud, A.; Woillard, J. B.; Rérolle, J. P.; Marquet, P., et al., Pharmacological Research 2013, 72, 52-60, http://doi.org/10.1016/j.phrs.2013.03.009
  125. Mri atlas of ectopic endometriosis, Dallaudière, B.; Salut, C.; Hummel, V.; Pouquet, M.; Piver, P.; Rouanet, J.-P.; Maubon, A., Diagnostic and Interventional Imaging 2013, 94, 263-280, http://doi.org/10.1016/j.diii.2012.10.020
  126. Free radical scavenging by natural polyphenols: Atom versus electron transfer, Di Meo, F.; Lemaur, V.; Cornil, J.; Lazzaroni, R.; Duroux, J.-L.; Olivier, Y.; Trouillas, P., The Journal of Physical Chemistry. A 2013, 117, 2082-2092, http://doi.org/10.1021/jp3116319
  127. Acylglucuronide in alkaline conditions: Migration vs. Hydrolysis, Di Meo, F.; Steel, M.; Nicolas, P.; Marquet, P.; Duroux, J.-L.; Trouillas, P., Journal of Molecular Modeling 2013, 19, 2423-2432, http://doi.org/10.1007/s00894-013-1790-3
  128. Application of recent double-hybrid density functionals to low-lying singlet-singlet excitation energies of large organic compounds, Di Meo, F.; Trouillas, P.; Adamo, C.; Sancho-García, J. C., The Journal of Chemical Physics 2013, 139, 164104, http://doi.org/10.1063/1.4825359
  129. Serum and lymphocytic neurotrophins profiles in systemic lupus erythematosus: A case-control study, Fauchais, A.-L.; Lise, M.-C.; Marget, P.; Lapeybie, F.-X.; Bezanahary, H.; Martel, C.; Dumonteil, S.; Sparsa, A., et al., PloS One 2013, 8, e79414, http://doi.org/10.1371/journal.pone.0079414
  130. Ciclosporin population pharmacokinetics and bayesian estimation in thoracic transplant recipients, Fruit, D.; Rousseau, A.; Amrein, C.; Rollé, F.; Kamar, N.; Sebbag, L.; Redonnet, M.; Epailly, E., et al., Clinical Pharmacokinetics 2013, 52, 277-288, http://doi.org/10.1007/s40262-013-0037-x
  131. [renal urinary shear stress: A novel actor in nephropathies], Gonzalez, J.; Essig, M.; Klein, J.; Caubet, C.; Dissard, R.; Bascands, J.-L.; Schanstra, J. P.; Buffin-Meyer, B., Medecine Sciences: M/S 2013, 29, 279-285, http://doi.org/10.1051/medsci/2013293014
  132. Obscure bleeding colonic duplication responds to proton pump inhibitor therapy, Jacques, J.; Projetti, F.; Legros, R.; Valgueblasse, V.; Sarabi, M.; Carrier, P.; Fredon, F.; Bouvier, S., et al., World Journal of Gastroenterology 2013, 19, 5940-5942, http://doi.org/10.3748/wjg.v19.i35.5940
  133. Monitoring of metformin-induced lactic acidosis in a diabetic patient with acute kidney failure and effect of hemodialysis, Laforest, C.; Saint-Marcoux, F.; Amiel, J.-B.; Pichon, N.; Merle, L., International Journal of Clinical Pharmacology and Therapeutics 2013, 51, 147-151, http://doi.org/10.5414/CP201728
  134. Adverse drug reactions in patients with alzheimer’s disease and related dementia in france: A national multicentre cross-sectional study, Laroche, M.-L.; Perault-Pochat, M.-C.; Ingrand, I.; Merle, L.; Kreft-Jais, C.; Castot-Villepelet, A.; Durrieu, G.; Gras, V., et al., Pharmacoepidemiology and Drug Safety 2013, 22, 952-960, http://doi.org/10.1002/pds.3471
  135. Distribution of total DNA and cccdna in serum and pbmcs may reflect the hbv immune status in hbsag+ and hbsag- patients coinfected or not with hiv or hcv, Loustaud-Ratti, V.; Wagner, A.; Carrier, P.; Marczuk, V.; Chemin, I.; Lunel, F.; Fouchard-Hubert, I.; Ahmed, S. S., et al., Clinics and Research in Hepatology and Gastroenterology 2013, 37, 373-383, http://doi.org/10.1016/j.clinre.2012.11.002
  136. [the role of immunosuppressive agents in kawasaki disease: A discussion of two cases], Peyre, M.; Laroche, C.; Etchecopar, C.; Brosset, P., Archives De Pediatrie: Organe Officiel De La Societe Francaise De Pediatrie 2013, 20, 748-753, http://doi.org/10.1016/j.arcped.2013.04.002
  137. The pharmacokinetic interaction between mycophenolic acid and cyclosporine revisited: A commentary on « mycophenolic acid glucuronide is transported by multidrug resistance-associated protein 2 and this transport is not inhibited by cyclosporine, tacrolimus or sirolimus », Picard, N., Xenobiotica; the Fate of Foreign Compounds in Biological Systems 2013, 43, 836-838, http://doi.org/10.3109/00498254.2012.761742
  138. Describing perceived stigma against alzheimer’s disease in a general population in france: The stig-ma survey, Piver, L. C.; Nubukpo, P.; Faure, A.; Dumoitier, N.; Couratier, P.; Clément, J.-P., International Journal of Geriatric Psychiatry 2013, 28, 933-938, http://doi.org/10.1002/gps.3903
  139. Lessons from routine dose adjustment of tacrolimus in renal transplant patients based on global exposure, Saint-Marcoux, F.; Woillard, J.-B.; Jurado, C.; Marquet, P., Therapeutic Drug Monitoring 2013, 35, 322-327, http://doi.org/10.1097/FTD.0b013e318285e779
  140. Mechanism of one-electron oxidation of metformin in aqueous solution, Trouillas, P.; Marchetti, C.; Bonnefont-Rousselot, D.; Lazzaroni, R.; Jore, D.; Gardès-Albert, M.; Collin, F., Physical chemistry chemical physics: PCCP 2013, 15, 9871-9878, http://doi.org/10.1039/c3cp50602a
  141. Effect of cyp3a4*22, por*28, and ppara rs4253728 on sirolimus in vitro metabolism and trough concentrations in kidney transplant recipients, Woillard, J.-B.; Kamar, N.; Coste, S.; Rostaing, L.; Marquet, P.; Picard, N., Clinical Chemistry 2013, 59, 1761-1769, http://doi.org/10.1373/clinchem.2013.204990
  142. Therapy response evaluation with fdg-pet/ct in small cell lung cancer: A prognostic and comparison study of the percist and eortc criteria, Ziai, D.; Wagner, T.; El Badaoui, A.; Hitzel, A.; Woillard, J. B.; Melloni, B.; Monteil, J., Cancer Imaging: The Official Publication of the International Cancer Imaging Society 2013, 13, 73-80, http://doi.org/10.1102/1470-7330.2013.0008
  143. Prevention of infections during primary immunodeficiency, Aguilar, C.; Malphettes, M.; Donadieu, J.; Chandesris, O.; Coignard-Biehler, H.; Catherinot, E.; Pellier, I.; Stephan, J.-L., et al., Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2014, 59, 1462-1470, http://doi.org/10.1093/cid/ciu646
  144. [multicentric study of medical care and practices in spinal muscular atrophy type 1 over two 10-year periods], Barnérias, C.; Quijano, S.; Mayer, M.; Estournet, B.; Cuisset, J.-M.; Sukno, S.; Peudenier, S.; Laroche, C., et al., Archives De Pediatrie: Organe Officiel De La Societe Francaise De Pediatrie 2014, 21, 347-354, http://doi.org/10.1016/j.arcped.2014.01.017
  145. Transient neonatal liver disease after maternal antenatal intravenous ig infusions in gestational alloimmune liver disease associated with neonatal haemochromatosis, Baruteau, J.; Heissat, S.; Broué, P.; Collardeau-Frachon, S.; Bouvier, R.; Fabre, M.; Debiec, H.; Ronco, P., et al., Journal of Pediatric Gastroenterology and Nutrition 2014, 59, 629-635, http://doi.org/10.1097/MPG.0000000000000514
  146. [interest of ugt1a1 genotyping within digestive cancers treatment by irinotecan], Boyer, J.-C.; Etienne-Grimaldi, M.-C.; Thomas, F.; Quaranta, S.; Picard, N.; Loriot, M.-A.; Poncet, D.; Gagnieu, M.-C., et al., Bulletin Du Cancer 2014, 101, 533-553, http://doi.org/10.1684/bdc.2014.1933
  147. Management of presumed benign ovarian tumors: Updated french guidelines, Brun, J.-L.; Fritel, X.; Aubard, Y.; Borghese, B.; Bourdel, N.; Chabbert-Buffet, N.; Collinet, P.; Deffieux, X., et al., European Journal of Obstetrics, Gynecology, and Reproductive Biology 2014, 183, 52-58, http://doi.org/10.1016/j.ejogrb.2014.10.012
  148. Calcineurin activity assay measurement by liquid chromatography-tandem mass spectrometry in the multiple reaction monitoring mode, Carr, L.; Gagez, A.-L.; Essig, M.; Sauvage, F.-L.; Marquet, P.; Gastinel, L. N., Clinical Chemistry 2014, 60, 353-360, http://doi.org/10.1373/clinchem.2013.213264
  149. Severe renal impairment during triple therapy with telaprevir, Carrier, P.; Chambaraud, T.; Vong, C.; Guillaudeau, A.; Debette-Gratien, M.; Jacques, J.; Legros, R.; Sautereau, D., et al., Clinics and Research in Hepatology and Gastroenterology 2014, 38, e69-71, http://doi.org/10.1016/j.clinre.2013.12.005
  150. [non-cirrhotic ascites: Pathophysiology, diagnosis and etiology], Carrier, P.; Jacques, J.; Debette-Gratien, M.; Legros, R.; Sarabi, M.; Vidal, E.; Sautereau, D.; Bezanahary, H., et al., La Revue De Medecine Interne 2014, 35, 365-371, http://doi.org/10.1016/j.revmed.2013.12.001
  151. Evolution of direct costs in the first years of rheumatoid arthritis: Impact of early versus late biologic initiation–an economic analysis based on the espoir cohort, Chevreul, K.; Haour, G.; Lucier, S.; Harvard, S.; Laroche, M.-L.; Mariette, X.; Saraux, A.; Durand-Zaleski, I., et al., PloS One 2014, 9, e97077, http://doi.org/10.1371/journal.pone.0097077
  152. Probable drug-induced liver injury associated with aliskiren: Case report and review of adverse event reports from pharmacovigilance databases, Crepin, S.; Godet, B.; Carrier, P.; Villeneuve, C.; Merle, L.; Laroche, M.-L., American journal of health-system pharmacy: AJHP: official journal of the American Society of Health-System Pharmacists 2014, 71, 643-647, http://doi.org/10.2146/ajhp130149
  153. Pharmacokinetics and exposure-effect relationships of capecitabine in elderly patients with breast or colorectal cancer, Daher Abdi, Z.; Lavau-Denes, S.; Prémaud, A.; Urien, S.; Sauvage, F. L.; Martin, J.; Leobon, S.; Marquet, P., et al., Cancer Chemotherapy and Pharmacology 2014, 73, 1285-1293, http://doi.org/10.1007/s00280-014-2466-0
  154. Exposure to mycophenolic acid better predicts immunosuppressive efficacy than exposure to calcineurin inhibitors in renal transplant patients, Daher Abdi, Z.; Prémaud, A.; Essig, M.; Alain, S.; Munteanu, E.; Garnier, F.; Le Meur, Y.; Marquet, P., et al., Clinical Pharmacology and Therapeutics 2014, 96, 508-515, http://doi.org/10.1038/clpt.2014.140
  155. Temperature dependence of binding and catalysis for human serum arylesterase/paraoxonase, Debord, J.; Bollinger, J.-C.; Harel, M.; Dantoine, T., Biochimie 2014, 97, 72-77, http://doi.org/10.1016/j.biochi.2013.09.022
  156. Hysteroscopy: Guidelines for clinical practice from the french college of gynaecologists and obstetricians, Deffieux, X.; Gauthier, T.; Menager, N.; Legendre, G.; Agostini, A.; Pierre, F.; Obstetricians, F. C. o. G. a., European Journal of Obstetrics, Gynecology, and Reproductive Biology 2014, 178, 114-122, http://doi.org/10.1016/j.ejogrb.2014.04.026
  157. [epidural analgesia apart from obstetrics: A survey of practice], Gagnoud, R.; Woillard, J. B.; Ponsonnard, S.; Cros, J.; Youssef, B.; Nathan, N., Annales Francaises D’anesthesie Et De Reanimation 2014, 33, 318-325, http://doi.org/10.1016/j.annfar.2014.03.015
  158. Transperineal versus transvaginal ultrasound cervical length measurement and preterm labor, Gauthier, T.; Marin, B.; Garuchet-Bigot, A.; Kanoun, D.; Catalan, C.; Caly, H.; Eyraud, J.-L.; Aubard, Y., Archives of Gynecology and Obstetrics 2014, 290, 465-469, http://doi.org/10.1007/s00404-014-3229-1
  159. Pelvic magnetic resonance imaging in the ewe: A model for experimental gynecologic research, Gauthier, T.; Marquet, P.; Kanoun, D.; Maubon, A.; Piver, P.; Couquet, C.; Aubard, Y., The Journal of Obstetrics and Gynaecology Research 2014, 40, 133-138, http://doi.org/10.1111/jog.12141
  160. Uterus retrieval process from brain dead donors, Gauthier, T.; Piver, P.; Pichon, N.; Bibes, R.; Guillaudeau, A.; Piccardo, A.; Pesteil, F.; Tricard, J., et al., Fertility and Sterility 2014, 102, 476-482, http://doi.org/10.1016/j.fertnstert.2014.04.016
  161. [uterus transplantation: Tomorrow?], Gauthier, T.; Piver, P.; Pichon, N.; Essig, M.; Marquet, P.; Aubard, Y., Gynecologie, Obstetrique & Fertilite 2014, 42, 741-743, http://doi.org/10.1016/j.gyobfe.2014.09.010
  162. [follow-up of endometrial cancer], Gauthier, T.; Siegerth, F.; Monteil, J.; Jammet, I.; Saidi, N.; Tubiana-Mathieu, N.; Aubard, Y., Bulletin Du Cancer 2014, 101, 741-747, http://doi.org/10.1684/bdc.2014.1947
  163. Obscure bleeding from gastrointestinal metastases of a head and neck squamous cell carcinoma, Jacques, J.; Geyl, S.; Projetti, F.; Carrier, P.; Le-Sidaner, A.; Sautereau, D.; Legros, R., Endoscopy 2014, 46 Suppl 1 UCTN, E18-19, http://doi.org/10.1055/s-0033-1344799
  164. Usefulness and reliability of two- and three-dimensional computed tomography in patients older than 65 years with distal humerus fractures, Jacquot, A.; Poussange, N.; Charrissoux, J.-L.; Clavert, P.; Obert, L.; Pidhorz, L.; Sirveaux, F.; Mansat, P., et al., Orthopaedics & traumatology, surgery & research: OTSR 2014, 100, 275-280, http://doi.org/10.1016/j.otsr.2014.01.003
  165. [resection of iliac vessels and adnexial cancer: Report of 2 cases], Lacorre, A.; Gauthier, T.; Gardet, E.; Berger, J.; Loum, O.; Monteil, J.; Tubiana, N.; Aubard, Y., Gynecologie, Obstetrique & Fertilite 2014, 42, 265-268, http://doi.org/10.1016/j.gyobfe.2013.11.001
  166. Ulceration of the oral mucosa following direct contact with ferrous sulfate in elderly patients: A case report and a review of the french national pharmacovigilance database, Liabeuf, S.; Gras, V.; Moragny, J.; Laroche, M.-L.; Andrejak, M.; Centers, F. N. N. o. P., Clinical Interventions in Aging 2014, 9, 737-740, http://doi.org/10.2147/CIA.S58394
  167. Renal impairment is frequent in chronic hepatitis c patients under triple therapy with telaprevir or boceprevir, Loustaud-Ratti, V.; Carrier, P.; Vong, C.; Essig, M., Hepatology (Baltimore, Md.) 2014, 59, 2426, http://doi.org/10.1002/hep.26730
  168. Consensus conference on a composite endpoint for clinical trials on immunosuppressive drugs in lung transplantation, Monchaud, C.; Marin, B.; Estenne, M.; Preux, P.-M.; Marquet, P.; Group, e.-L. T., Transplantation 2014, 98, 1331-1338, http://doi.org/10.1097/TP.0000000000000235
  169. Are adverse drug reaction patterns different between romiplostim and eltrombopag? 2009-2013 french pharmacovigilance assessment, Moulis, G.; Bagheri, H.; Sailler, L.; Jonville-Bera, A.-P.; Weber, E.; Guy, C.; Petitpain, N.; Laroche, M.-L., et al., European Journal of Internal Medicine 2014, 25, 777-780, http://doi.org/10.1016/j.ejim.2014.09.006
  170. Opposite effects of angiotensins receptors type 2 and type 4 on streptozotocin induced diabetes vascular alterations in mice, Nasser, M.; Clere, N.; Botelle, L.; Javellaud, J.; Oudart, N.; Faure, S.; Achard, J.-M., Cardiovascular Diabetology 2014, 13, 40, http://doi.org/10.1186/1475-2840-13-40
  171. Tacrolimus pharmacodynamics and pharmacogenetics along the calcineurin pathway in human lymphocytes, Noceti, O. M.; Woillard, J.-B.; Boumediene, A.; Esperón, P.; Taupin, J.-L.; Gerona, S.; Valverde, M.; Touriño, C., et al., Clinical Chemistry 2014, 60, 1336-1345, http://doi.org/10.1373/clinchem.2014.223511
  172. Cyclosporine therapeutic window evaluation by chebyshev’s inequality method in kidney recipients, Noreikaitė, A.; Saint-Marcoux, F.; Kaduševičius, E.; Stankevičius, E., Medicina (Kaunas, Lithuania) 2014, 50, 37-43, http://doi.org/10.1016/j.medici.2014.05.008
  173. Cis-trans isomerization of silybins a and b, Novotná, M.; Gažák, R.; Biedermann, D.; Di Meo, F.; Marhol, P.; Kuzma, M.; Bednárová, L.; Fuksová, K., et al., Beilstein Journal of Organic Chemistry 2014, 10, 1047-1063, http://doi.org/10.3762/bjoc.10.105
  174. Benchmarking of force fields for molecule-membrane interactions, Paloncýová, M.; Fabre, G.; DeVane, R. H.; Trouillas, P.; Berka, K.; Otyepka, M., Journal of Chemical Theory and Computation 2014, 10, 4143-4151, http://doi.org/10.1021/ct500419b
  175. Quercetin-imprinted chromatographic sorbents revisited: Optimization of synthesis and rebinding protocols for application to natural resources, Pardo, A.; Mespouille, L.; Blankert, B.; Trouillas, P.; Surin, M.; Dubois, P.; Duez, P., Journal of Chromatography. A 2014, 1364, 128-139, http://doi.org/10.1016/j.chroma.2014.08.064
  176. Elucidation of antioxidant properties of wood bark derived saturated diarylheptanoids: A comprehensive (dft-supported) understanding, Ponomarenko, J.; Trouillas, P.; Martin, N.; Dizhbite, T.; Krasilnikova, J.; Telysheva, G., Phytochemistry 2014, 103, 178-187, http://doi.org/10.1016/j.phytochem.2014.03.010
  177. Light chain deposition disease without glomerular proteinuria: A diagnostic challenge for the nephrologist, Sicard, A.; Karras, A.; Goujon, J.-M.; Sirac, C.; Bender, S.; Labatut, D.; Callard, P.; Sarkozy, C., et al., Nephrology, Dialysis, Transplantation: Official Publication of the European Dialysis and Transplant Association – European Renal Association 2014, 29, 1894-1902, http://doi.org/10.1093/ndt/gfu045
  178. Adjuvant chemotherapy in node-negative breast cancer: Upa/pai-1 determinations for 163 cases, Vénat-Bouvet, L.; Fermeaux, V.; Leobon, S.; Saidi, N.; Monteil, J.; Mollard, J.; Aubard, Y.; Jammet, I., et al., Anticancer Research 2014, 34, 1213-1217,
  179. Pharmacokinetics of mycophenolate mofetil in children with lupus and clinical findings in favour of therapeutic drug monitoring, Woillard, J.-B.; Bader-Meunier, B.; Salomon, R.; Ranchin, B.; Decramer, S.; Fischbach, M.; Berard, E.; Guigonis, V., et al., British Journal of Clinical Pharmacology 2014, 78, 867-876, http://doi.org/10.1111/bcp.12392
  180. Pharmacokinetic tools for the dose adjustment of ciclosporin in haematopoietic stem cell transplant patients, Woillard, J.-B.; Lebreton, V.; Neely, M.; Turlure, P.; Girault, S.; Debord, J.; Marquet, P.; Saint-Marcoux, F., British Journal of Clinical Pharmacology 2014, 78, 836-846, http://doi.org/10.1111/bcp.12394
  181. Associations between polymorphisms in target, metabolism, or transport proteins of mycophenolate sodium and therapeutic or adverse effects in kidney transplant patients, Woillard, J.-B.; Picard, N.; Thierry, A.; Touchard, G.; Marquet, P.; group, D. s., Pharmacogenetics and Genomics 2014, 24, 256-262, http://doi.org/10.1097/FPC.0000000000000045